Esomeprazole once daily for 6 months is effective therapy for maintaining healed erosive esophagitis and for controlling gastroesophageal reflux disease symptoms: a randomized, double-blind, placebo-controlled study of efficacy and safety
暂无分享,去创建一个
D. Johnson | N. Vakil | S. Benjamin | B. Hamelin | D. D'Amico | J. Goldstein | M. Lamet | J. Whipple
[1] G. Falk,et al. Esomeprazole improves healing and symptom resolution as compared with omeprazole in reflux oesophagitis patients: a randomized controlled trial , 2000, Alimentary pharmacology & therapeutics.
[2] K. Röhss,et al. Esomeprazole 40 mg provides more effective acid control than omeprazole 40 mg , 2000, American Journal of Gastroenterology.
[3] K. Röhss,et al. Esomeprazole provides improved acid control vs. omeprazole in patients with symptoms of gastro‐oesophageal reflux disease , 2000, Alimentary pharmacology & therapeutics.
[4] T. Andersson,et al. Pharmacokinetics (PK) and effect on pentagastrin stimulated peak acid output (PAO) of omeprazole (O) and its 2 optical isomers, S-omeprazole/esomeprazole (E) and R-omeprazole (R-O) , 2000 .
[5] D. Levine,et al. Safety of long-term treatment with a new PPI, esomeprazole in gerd patients , 2000 .
[6] N. Vakil,et al. Safety and efficacy of long-term treatment with esomeprazole in patients with healed erosive esophagitis (EE) , 2000 .
[7] A. Blum,et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification , 1999, Gut.
[8] A. Zangrandi,et al. Natural history, clinicopathologic classification and prognosis of gastric ECL cell tumors. , 1998, The Yale journal of biology and medicine.
[9] P J Kahrilas,et al. An evidence-based appraisal of reflux disease management — the Genval Workshop Report , 1998, Gut.
[10] N. Chiba. Proton pump inhibitors in acute healing and maintenance of erosive or worse esophagitis: a systematic overview. , 1997, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.
[11] M F Dixon,et al. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. , 1996, The American journal of surgical pathology.
[12] Bardhan Kd. Duodenal ulcer and gastroesophageal reflux disease today: long-term therapy--a sideways glance. , 1996 .
[13] A. Pilotto,et al. A comparison of five maintenance therapies for reflux esophagitis. , 1995, The New England journal of medicine.
[14] P. Marquis,et al. Quality of life in patients with upper gastrointestinal symptoms: results from the Domestic/International Gastroenterology Surveillance Study (DIGEST). , 1999, Scandinavian journal of gastroenterology. Supplement.
[15] I. Wiklund,et al. Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. International GORD Study Group. , 1998, European journal of gastroenterology & hepatology.
[16] J. Dent,et al. The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease. , 1998, Scandinavian journal of gastroenterology.
[17] K. Bardhan. Duodenal ulcer and gastroesophageal reflux disease today: long-term therapy--a sideways glance. , 1996, The Yale journal of biology and medicine.
[18] L. Villani,et al. Hyperplastic, dysplastic, and neoplastic enterochromaffin-like-cell proliferations of the gastric mucosa. Classification and histogenesis. , 1995, The American journal of surgical pathology.